Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing the Utility of Cannabidiol Quantitation Methods for Use in High-Throughput In Vitro Assays.

ACS omega·2026
Same author

The growing impact of machine learning on drug formulation science.

Advanced drug delivery reviews·2025
Same author

American black bear (Ursus americanus) as a potential host for Campylobacter jejuni.

PloS one·2025
Same author

Polymer microparticles in an evolving drug delivery landscape: challenges and the role of machine learning.

International journal of pharmaceutics·2025
Same author

A dataset on formulation parameters and characteristics of drug-loaded PLGA microparticles.

Scientific data·2025
Same author

<i>Campylobacter jejuni</i> resistance to human milk involves the acyl carrier protein AcpP.

mBio·2025
Same journal

Dual-Targeted Radionuclide Therapy with <sup>161</sup>Tb Instigates Anticancer Immunity in "Cold" Murine Prostate Tumor.

Molecular pharmaceutics·2026
Same journal

Development of [<sup>111</sup>In]In-CHX-A″-DTPA-αCD68 for ImmunoSPECT to Image Murine Macrophages.

Molecular pharmaceutics·2026
Same journal

Mechanistic Insight into Self-Gelation Involved in Prescription Design for Optimization of Tablet Performance.

Molecular pharmaceutics·2026
Same journal

[<sup>68</sup>Ga]Ga-DOTA-DP-UBI 29-41: A Novel <sup>68</sup>Ga-Labeled Ubiquicidin 29-41 Derivative Containing d-Proline for Bacterial Infection PET Imaging.

Molecular pharmaceutics·2026
Same journal

Comparative Investigation of the Impact of Sodium Citrate Buffers on Lipid Nanoparticles of circRNA or Linear mRNA.

Molecular pharmaceutics·2026
Same journal

Preclinical Evaluation of <sup>177</sup>Lu-Labeled Anti-CLDN18.2 VHH-Fc for Radioimmunotherapy in Gastric Cancer.

Molecular pharmaceutics·2026
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

5.8K

A Data-Driven Workflow for Nanomedicine Optimization Using Active Learning and Automated Experimentation.

Zeqing Bao1, Frantz Le Devedec1, Steven Huynh2

  • 1Acceleration Consortium, University of Toronto, Toronto, Ontario M5S 3H6, Canada.

Molecular Pharmaceutics
|October 25, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces an AI-driven workflow to accelerate nanomedicine development. It efficiently identifies optimal nanoformulations with improved solubility and stability, overcoming traditional limitations.

Keywords:
Bayesian optimizationactive learningautomated experimentationnanomedicineself-driving lab

More Related Videos

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

599
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.4K

Related Experiment Videos

Last Updated: Jan 14, 2026

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

5.8K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

599
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.4K

Area of Science:

  • Pharmaceutical Sciences
  • Materials Science
  • Computational Chemistry

Background:

  • Nanomedicines offer enhanced solubility for hydrophobic drugs.
  • Current nanomedicine development is inefficient, hindering formulation optimization.
  • Developing optimal nanoformulations requires systematic screening and fine-tuning.

Purpose of the Study:

  • To develop a data-driven workflow integrating active learning and experimental automation for rapid identification of optimal nanoformulations.
  • To overcome the limitations of current nanomedicine development methodologies.
  • To accelerate the discovery of high-performing nanoformulations for poorly soluble drugs.

Main Methods:

  • An active learning-robotic system was used to navigate a vast formulation design space (17 billion possibilities).
  • A design of experiments approach refined the search space for selected formulations.
  • Manual preparation, purification, and characterization of lead nanoformulations were performed.

Main Results:

  • A panel of high-performing lead nanoformulations was identified within weeks.
  • Identified nanoformulations demonstrated improved solubility, small and uniform particle size, and storage stability.
  • The workflow significantly accelerated the identification of optimal nanoformulation candidates.

Conclusions:

  • Combining AI-driven design with automation accelerates nanomedicine development.
  • This approach enables efficient formulation development for poorly soluble drugs.
  • The workflow lays the groundwork for more efficient and systematic nanomedicine discovery.